Skip to main content
Erschienen in: Child and Adolescent Psychiatry and Mental Health 1/2016

Open Access 01.12.2016 | Commentary

Overview: referrals for genetic evaluation from child psychiatrists

verfasst von: Katharine R. Press, Laura Wieczorek, Julie Hoover-Fong, Joann Bodurtha, Lynn Taylor

Erschienen in: Child and Adolescent Psychiatry and Mental Health | Ausgabe 1/2016

Abstract

A growing multitude of known genetic diagnoses can result in presentation to child psychiatry. For numerous reasons, it is important to identify a genetic etiology in child psychiatry patients when it is present. Genetic diagnoses can guide treatment and enable access to specialized clinics and appropriate screening measures. They can also allow for genetic counseling for the patient and family. A better understanding of etiology with a named diagnosis can itself be of great value to many patients and families; prognostic information can be empowering. Since patients with genetic conditions may present to psychiatric care in diverse ways, child psychiatrists must decide who to refer for genetic evaluation. Here we create a table to provide a framework of concerning/notable history and exam features that a practicing child psychiatrist may encounter that should prompt one to consider whether a larger, unifying genetic diagnosis is at hand. We hope this framework will facilitate referral of child psychiatry patients to genetics so that more patients can benefit from an appropriate diagnosis.

Background

A growing multitude of known genetic diagnoses can result in presentation to child psychiatry. The prevalence of genetic diagnoses among child psychiatry patients is best studied for autism, where 10–20 % of cases have a diagnosable genetic cause [e.g. Fragile X (FXS)] [16]. There is little information about the prevalence of genetic conditions in child psychiatry patients more generally. There are a large number of different genetic conditions that may lead to psychiatric presentation in a child. A December 2015 search of the Online Mendelian Inheritance in Man database (OMIM.org®), a catalog of genetic conditions, reveals 42 genetic etiologic associations for both psychiatric symptoms and autism. As genetic understanding continues to progress, the overlap with child psychiatry grows and it becomes increasingly important for child psychiatrists to recognize signs of a possible underlying genetic diagnoses [7].
In some instances, a genetic condition may have a typical psychiatric presentation and psychiatric symptoms may appear isolated. In such cases, presentation may be indistinguishable from that of a typical psychiatric patient whose disease is polygenic and multifactorial and genetic diagnosis is more difficult [8]. However, in many cases a genetic etiology may be suggested by features of history or physical exam. If child psychiatrists are aware of red flags signifying possible genetic condition, more patients can be appropriately diagnosed.
This article addresses two questions: Why is it important to diagnose genetic conditions in child psychiatry patients? What should prompt a child psychiatrist to request a genetic consult for a patient?

Main text

Benefits of diagnosing genetic conditions

Identifying a genetic etiology in child psychiatry patients has many benefits [9]. Diagnosis of specific genetic conditions can guide treatment and allow access to specialized healthcare. For example, depression may herald Wilson disease, which can be effectively treated with chelators [10]. In metabolic disorders with psychiatric symptoms, a diagnosis can allow for appropriate management to avoid metabolic decompensations, which worsen both psychiatric and somatic symptoms [8]. In children with FXS, hyperactivity responds particularly well to methylphenidate. Hyperactivity is more responsive to methylphenidate as part of FXS versus part of autism spectrum disorder or intellectual disability, or possibly even non-specific ADHD [3]. When diagnosed, these patients can be put directly on methylphenidate and avoid many medication trials, which carry associated risks. Furthermore, because psychiatric symptoms may arise years before more specific organic signs, certain treatments may be more effective at the ‘psychiatric stage’ before occurrence of irreversible lesions. This is particularly true for metabolic disorders [11]. Genetic diagnosis also enables access to specialized clinics with greater understanding of and experience with these complex presentations [12]. There are a growing number of condition-specific and neurogenetic clinics that may be very beneficial to patients. Because wait times to appointments can be challenging, other consultation strategies (e.g. telehealth) may be considered.
Additionally, some genetic conditions are associated with known medical complications and may require routine screening or further medical work-up. For example, a patient presenting with autism spectrum disorder and macrocephaly who is found to have a PTEN mutation can then be enrolled in a cancer screening protocol. Further, diagnosis can allow for appropriate genetic counseling for the patient and family [12, 13].
Finally, a better understanding of etiology with a named diagnosis may itself be of great value to many. Most individuals would rather know they have a serious disease than continue without a diagnosis [14]. Diagnosis allows for improved understanding, educational planning, and social support, and peer networking [15, 16]. Prognostic information can be empowering.

Indications for genetic consultation

It is not practical to conduct a genetic workup on all patients, so child psychiatrists must decide whom to refer for genetic evaluation [1]. Child psychiatrists are in an important position to diagnose genetic conditions, as they often see children for whom a diagnosis has been elusive, who have unusual presentations, or who have been difficult to treat.
Patients with genetic conditions may present to psychiatric care in diverse ways. Table 1 shows genetic conditions that may in rare cases account for typical child psychiatry presentations. Psychiatric symptoms may be apparently isolated, making genetic diagnosis difficult. However, often a careful history and physical provides hints to a genetic diagnosis.
Table 1
Genetic syndromes may in rare cases manifest in more general child psychiatry presentations
Psychiatric presentation
Example of genetic syndrome that may result in this presentation
Anxiety
22q11 deletion [17], Fragile X syndrome [18], Williams syndrome [19]
Acute psychosis
Adrenoleukodystrophy [20], Porphyria [21], Niemann-Pick [21], 22q11 deletion [17]
Conduct disorder/poor judgment/anger
Monoamine oxidase A deficiency [22]
Hyperactivity
Turner syndrome [23], Fragile X syndrome [3]
Depression
Wilson disease [24]
Some unusual psychiatric presentations or behaviors may suggest a particular genetic etiology. Skin picking may occur in Prader-Willi syndrome [25] while severe disruptions of sleep and nail pulling suggest Smith-Magenis syndrome [26]. In many cases, non-psychiatric features of the history or exam will provide clues to genetic etiology.
The purpose of Table 2 is to present a framework of notable history and exam features that should prompt a child psychiatrist to consider whether there is a larger, unifying genetic diagnosis at hand. All of these features are recognized as markers in pediatric genetic practice, however here the goal is to isolate the flags most likely to present in a child psychiatry practice [27]. This table is just a starting point and should not be considered exhaustive.
Table 2
Red flags for a possible genetic diagnosis in child psychiatry patients
Red flag
Explanation
Examples of genetic conditions that may include specific psychiatric components
Medical history
 Autism spectrum disorder
Genetic causes can be identified in 10–20 % of autism patients [16]
Rett syndrome
PTEN mutations
Tuberous sclerosis
Chromosomal copy number variants
 Intellectual disability or global developmental delay
While these findings may be purely developmental, they should be investigated further when the findings seem out of proportion to the level of developmental delay
Rett syndrome
fragile X
 Psychiatric symptoms worsening with conditions leading to increased protein catabolism, such as fever, surgery, or prolonged fasting
May indicate metabolic dysfunction
 
 Unusually severe presentation or prolonged recovery after minor illness
Acute intermittent porphyria
 Cyclic or recurrent vomiting, particularly with protein intake
Organic acidemias
Inborn error in pyruvate metabolism
 Poor or atypical treatment response to medications or behavioral interventions
May indicate an alternate or additional diagnosis to explain nonstandard response/components
Prader-Willi syndrome
 Severely disrupted sleep
Smith-Magenis syndrome
 Self-injurious behavior or skin picking
Lesch-Nyhan syndrome, Prader-Willi syndrome
Family history
 Significant family history of psychiatric conditions
Though purely psychiatric conditions may also follow a familial pattern, this could indicate an underlying genetic diagnosis
22q11 deletion syndrome
 Significant family history of neurologic regression or progressive neurologic disorders
May represent certain autosomal dominant traits for which first symptoms are sometimes psychiatric
Huntington disease
Spinocerebellar ataxias
 Family history of relatives with intellectual disabilities or many with learning disabilities
Intellectual disability and learning disabilities are part of many genetic syndromes that also have psychiatric features
Fragile X syndrome
 Born to a parent with a known cytogenetic abnormality (e.g. balanced translocation) or recurrent pregnancy loss
Translocations may become unbalanced in subsequent generations causing a variety of presentations including psychiatric disease and pregnancy loss
Unbalanced chromosomal complement
Physical exam
 Dysmorphic features that are not familial
May be caused by genetic syndrome
22q11 deletion syndrome
Fragile X
Submicroscopic chromosomal deletions and duplications
Lysosomal storage diseases
 Single major or multiple minor and/or major physical anomalies
Branchio-oto-renal syndrome
Holt Oram syndrome
Chromosomal deletions or deletions
 Striking inability to learn after many well-controlled trials
May suggest cortical dysfunction
Fragile X
 Hepatosplenomegaly
These findings would not be explained by a psychiatric diagnosis alone. In conjunction with psychiatric symptoms, these findings may suggest a unifying genetic diagnosis.
Gaucher disease
Niemann-Pick disease
Mucopolysaccharidoses
 Unusual body odor
Glutaric aciduria type II
Phenylketonuria
Isovaleric academia
Maple syrup urine disease
 Unusual dermatologic findings: multiple types of lesions, six or more café au lait macules >1.5 cm in diameter, multiple lipomas, albinism
Neurofibromatosis type I
Cowden syndrome
Hermansky-Pudlak syndrome
 Unexplained neurologic findings
  Intractable seizures
  Hypertonia or hypotonia
  Peripheral neuropathy
  Myopathy
  Progressive ataxia
Gaucher disease
Neuronal ceroid lipofuscinosis
Mitochondrial disorders
Inborn errors of metabolism including leukodystrophies
Prader-Willi syndrome
Angelman syndrome Charcot-Marie-Tooth disease
Spinocerebellar ataxias
 Evidence of a connective tissue disorder
  Joint laxity
  Poor wound healing
  Marfanoid habitus
Homocystinuria
Ehlers Danlos syndrome
 Unexplained lab anomalies
  Acidosis
  Persistent hypoglycemia
  Adrenal insufficiency
Organic acidemias
Beckwith-Wiedemann syndrome
Adrenoleukodystrophy
 Abnormal brain MRI findings
Tuberous sclerosis
Leukodystrophies
Spinocerebellar ataxias, Alexander disease
 Microcephaly
Fetal alcohol syndrome, Williams syndrome
 Failure to thrive or short stature
While psychiatric illness may lead to growth abnormalities, these abnormalities should be evaluated further when they cannot be fully explained by psychiatric disease
Various chromosomal conditions
If one or more of these red flags are present, a child psychiatrist should consider requesting a genetic consultation. Whenever possible, genetic tests should be ordered in conjunction with a genetic team. On a practical level, determining which genetic tests to order can be confusing and outside the usual practice of most child psychiatrists. Even more important, many child psychiatrists are not comfortable explaining the intricacies of genetic testing and lack the infrastructure to deal with ramifications of positive results [28]. Informed consent must include discussion of the risks of genetic testing, which include harms associated with resultant treatments and incidental findings that can be life changing or psychologically disruptive [29]. There may be particular cases in which a child psychiatrist has experience with or training relevant to a certain genetic test and feels comfortable ordering this test, so this remains an individual call. However, in most cases it is best to involve a genetic team and employ their associated infrastructure. It is our hope that this table will help child psychiatrists communicate with genetic teams by allowing them to pinpoint the red flags that led them to consider a genetic etiology.

Conclusions

It is important to identify a genetic etiology in child psychiatry patients when it is present, as it has implications for treatment and counseling. Patients with genetic conditions may have unusual psychiatric symptoms or other abnormal history and physical findings. Here we present a table of red flags that a practicing child psychiatrist may identify, which could indicate an underlying genetic diagnosis. We hope this table will inspire child psychiatrists to think about genetic possibilities in their patient populations and make referrals for genetic evaluation when appropriate. Future work will be needed to validate this table in practice. However, being aware of these the flags has immediate utility in the clinical practice of child psychiatrists. To highlight how simple practice changes may have a big impact for diagnosing conditions, we provide a short list of tips and resources for making a genetic diagnosis in child psychiatry (Table 3). We hope that this commentary will encourage child psychiatrists to think about their growing overlap with the field of genetics. Recognition of the importance of genetic diagnoses in child psychiatry patients may stimulate more research into the prevalence of genetic disease, effective methods of screening and diagnosis, and strategies for treatment and management for these patients.
Table 3
Short list of tips and resources for making genetic diagnoses in child psychiatry
1.
Take a family history
2.
Measure and plot head circumference percentiles
3.
Inspect the skin
4.
Take note of dysmorphic features
5.
Know your genetics referral colleagues
6.
Short list of genetic resources
 Online Mendelian Inheritance in Man (OMIM)®: http://​www.​omim.​org/​
 Genetics Home Reference: http://​ghr.​nlm.​nih.​gov/​

Authors’ contributions

All authors have substantially contributed to the manuscript. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Schiff M, Benoist JF, Aissaoui S, Boespflug-Tanguy O, Mouren MC, de Baulny HO, Delorme R. Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders? PLoS One. 2011;6(7):e21932.CrossRefPubMedPubMedCentral Schiff M, Benoist JF, Aissaoui S, Boespflug-Tanguy O, Mouren MC, de Baulny HO, Delorme R. Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders? PLoS One. 2011;6(7):e21932.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, Anckarsater H, Rastam M, Smith CJ, Silverman JM, Hollander E, Leboyer M, Gillberg C, Verloes A, Betancur C. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(4):484–91.CrossRefPubMedPubMedCentral Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, Anckarsater H, Rastam M, Smith CJ, Silverman JM, Hollander E, Leboyer M, Gillberg C, Verloes A, Betancur C. Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet. 2007;144B(4):484–91.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Roberts JE, Miranda M, Boccia M, Janes H, Tonnsen BL, Hatton DD. Treatment effects of stimulant medication in young boys with fragile X syndrome. J Neurodev Disord. 2011;3(3):175–84.CrossRefPubMedPubMedCentral Roberts JE, Miranda M, Boccia M, Janes H, Tonnsen BL, Hatton DD. Treatment effects of stimulant medication in young boys with fragile X syndrome. J Neurodev Disord. 2011;3(3):175–84.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Cochran DM, Dvir Y, Frazier JA. “Autism-plus” spectrum disorders: intersection with psychosis and the schizophrenia spectrum. Child Adolesc Psychiatr Clin N Am. 2013;22(4):609–27.CrossRefPubMed Cochran DM, Dvir Y, Frazier JA. “Autism-plus” spectrum disorders: intersection with psychosis and the schizophrenia spectrum. Child Adolesc Psychiatr Clin N Am. 2013;22(4):609–27.CrossRefPubMed
5.
Zurück zum Zitat Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2014;86(5):749–64.CrossRef Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2014;86(5):749–64.CrossRef
6.
Zurück zum Zitat Shen J, Lincoln S, Miller DT. Advances in genetic discovery and implications for counseling of patients and families with autism spectrum disorders. Curr Genet Med Rep. 2014;2(3):124–34.CrossRef Shen J, Lincoln S, Miller DT. Advances in genetic discovery and implications for counseling of patients and families with autism spectrum disorders. Curr Genet Med Rep. 2014;2(3):124–34.CrossRef
7.
Zurück zum Zitat Hyman SE. The genetics of mental illness: implications for practice. Bull World Health Organ. 2000;78(4):455–63.PubMedPubMedCentral Hyman SE. The genetics of mental illness: implications for practice. Bull World Health Organ. 2000;78(4):455–63.PubMedPubMedCentral
8.
Zurück zum Zitat Sedel F, Baumann N, Turpin JC, Lyon-Caen O, Saudubray JM, Cohen D. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis. 2007;30(5):631–41.CrossRefPubMed Sedel F, Baumann N, Turpin JC, Lyon-Caen O, Saudubray JM, Cohen D. Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults. J Inherit Metab Dis. 2007;30(5):631–41.CrossRefPubMed
9.
Zurück zum Zitat ACMG Board of Directors. Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2015;17(6):505–7.CrossRef ACMG Board of Directors. Clinical utility of genetic and genomic services: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2015;17(6):505–7.CrossRef
10.
Zurück zum Zitat Zimbrean PC, Schilsky ML. The spectrum of psychiatric symptoms in Wilson’s disease: treatment and prognostic considerations. Am J Psychiatry. 2015;172(11):1068–72.CrossRefPubMed Zimbrean PC, Schilsky ML. The spectrum of psychiatric symptoms in Wilson’s disease: treatment and prognostic considerations. Am J Psychiatry. 2015;172(11):1068–72.CrossRefPubMed
12.
Zurück zum Zitat Schaefer GB, Mendelsohn NJ, Professional Practice and Guidelines Committee: Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med. 2013;15(5):399–407.CrossRefPubMed Schaefer GB, Mendelsohn NJ, Professional Practice and Guidelines Committee: Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med. 2013;15(5):399–407.CrossRefPubMed
13.
Zurück zum Zitat Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, Miles JH, Wang CH, Stratton R, Pilarski R, Eng C. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet. 2005;42(4):318–21.CrossRefPubMedPubMedCentral Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, Miles JH, Wang CH, Stratton R, Pilarski R, Eng C. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet. 2005;42(4):318–21.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Gahl WA, Tifft CJ. The NIH undiagnosed diseases program: lessons learned. JAMA. 2011;305(18):1904–5.CrossRefPubMed Gahl WA, Tifft CJ. The NIH undiagnosed diseases program: lessons learned. JAMA. 2011;305(18):1904–5.CrossRefPubMed
15.
Zurück zum Zitat Saul R. Medical genetics in pediatric practice. 1st ed. American Academy of Pediatrics; 2013. Saul R. Medical genetics in pediatric practice. 1st ed. American Academy of Pediatrics; 2013.
16.
Zurück zum Zitat Reiff M, Giarelli E, Bernhardt BA, Easley E, Spinner NB, Sankar PL, Mulchandani S. Parents’ perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders. J Autism Dev Disord. 2015;45(10):3262–75.CrossRefPubMed Reiff M, Giarelli E, Bernhardt BA, Easley E, Spinner NB, Sankar PL, Mulchandani S. Parents’ perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders. J Autism Dev Disord. 2015;45(10):3262–75.CrossRefPubMed
17.
Zurück zum Zitat Stephenson DD, Beaton EA, Weems CF, Angkustsiri K, Simon TJ. Identifying patterns of anxiety and depression in children with chromosome 22q11.2 deletion syndrome: comorbidity predicts behavioral difficulties and impaired functional communications. Behav Brain Res. 2015;276:190–8.CrossRefPubMedPubMedCentral Stephenson DD, Beaton EA, Weems CF, Angkustsiri K, Simon TJ. Identifying patterns of anxiety and depression in children with chromosome 22q11.2 deletion syndrome: comorbidity predicts behavioral difficulties and impaired functional communications. Behav Brain Res. 2015;276:190–8.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Saldarriaga W, Tassone F, Gonzalez-Teshima LY, Forero-Forero JV, Ayala-Zapata S, Hagerman R. Fragile X syndrome. Colomb Med (Cali). 2014;45(4):190–8. Saldarriaga W, Tassone F, Gonzalez-Teshima LY, Forero-Forero JV, Ayala-Zapata S, Hagerman R. Fragile X syndrome. Colomb Med (Cali). 2014;45(4):190–8.
19.
Zurück zum Zitat Ng R, Fillet P, DeWitt M, Heyman GD, Bellugi U. Reasoning about trust among individuals with Williams syndrome. Am J Intellect Dev Disabil. 2015;120(6):527–41.CrossRefPubMed Ng R, Fillet P, DeWitt M, Heyman GD, Bellugi U. Reasoning about trust among individuals with Williams syndrome. Am J Intellect Dev Disabil. 2015;120(6):527–41.CrossRefPubMed
20.
Zurück zum Zitat Ramos-Rios R, Berdullas J, Arauxo A, Santos-Garcia D. Schizophreniform psychosis at onset of adrenoleukodystrophy. CNS Spectr. 2009;14(12):711–2.PubMed Ramos-Rios R, Berdullas J, Arauxo A, Santos-Garcia D. Schizophreniform psychosis at onset of adrenoleukodystrophy. CNS Spectr. 2009;14(12):711–2.PubMed
22.
Zurück zum Zitat Bortolato M, Shih JC. Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol. 2011;100:13–42.CrossRefPubMedPubMedCentral Bortolato M, Shih JC. Behavioral outcomes of monoamine oxidase deficiency: preclinical and clinical evidence. Int Rev Neurobiol. 2011;100:13–42.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Russell HF, Wallis D, Mazzocco MM, Moshang T, Zackai E, Zinn AR, Ross JL, Muenke M. Increased prevalence of ADHD in Turner syndrome with no evidence of imprinting effects. J Pediatr Psychol. 2006;31(9):945–55.CrossRefPubMed Russell HF, Wallis D, Mazzocco MM, Moshang T, Zackai E, Zinn AR, Ross JL, Muenke M. Increased prevalence of ADHD in Turner syndrome with no evidence of imprinting effects. J Pediatr Psychol. 2006;31(9):945–55.CrossRefPubMed
24.
Zurück zum Zitat Alam ST, Rahman MM, Islam KA, Ferdouse Z. Neurologic manifestations, diagnosis and management of Wilson’s disease in children—an update. Mymensingh Med J. 2014;23(1):195–203.PubMed Alam ST, Rahman MM, Islam KA, Ferdouse Z. Neurologic manifestations, diagnosis and management of Wilson’s disease in children—an update. Mymensingh Med J. 2014;23(1):195–203.PubMed
25.
Zurück zum Zitat Rice LJ, Einfeld SL. Cognitive and behavioural aspects of Prader-Willi syndrome. Curr Opin Psychiatry. 2015;28(2):102–6.PubMed Rice LJ, Einfeld SL. Cognitive and behavioural aspects of Prader-Willi syndrome. Curr Opin Psychiatry. 2015;28(2):102–6.PubMed
26.
Zurück zum Zitat Finucane B, Dirrigl KH, Simon EW. Characterization of self-injurious behaviors in children and adults with Smith-Magenis syndrome. Am J Ment Retard. 2001;106(1):52–8.CrossRefPubMed Finucane B, Dirrigl KH, Simon EW. Characterization of self-injurious behaviors in children and adults with Smith-Magenis syndrome. Am J Ment Retard. 2001;106(1):52–8.CrossRefPubMed
27.
Zurück zum Zitat Pletcher BA, Toriello HV, Noblin SJ, Seaver LH, Driscoll DA, Bennett RL, Gross SJ. Indications for genetic referral: a guide for healthcare providers. Genet Med. 2007;9(6):385–9.CrossRefPubMedPubMedCentral Pletcher BA, Toriello HV, Noblin SJ, Seaver LH, Driscoll DA, Bennett RL, Gross SJ. Indications for genetic referral: a guide for healthcare providers. Genet Med. 2007;9(6):385–9.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Cohen J, Hoon A, Wilms Floet AM. Providing family guidance in rapidly shifting sand: informed consent for genetic testing. Dev Med Child Neurol. 2013;55(8):766–8.PubMed Cohen J, Hoon A, Wilms Floet AM. Providing family guidance in rapidly shifting sand: informed consent for genetic testing. Dev Med Child Neurol. 2013;55(8):766–8.PubMed
29.
Zurück zum Zitat Ross LF, Saal HM, David KL, Anderson RR, American Academy of Pediatrics, American College of Medical Genetics and Genomic: Technical report: Ethical and policy issues in genetic testing and screening of children. Genet Med. 2013;15(3):234–45.CrossRefPubMed Ross LF, Saal HM, David KL, Anderson RR, American Academy of Pediatrics, American College of Medical Genetics and Genomic: Technical report: Ethical and policy issues in genetic testing and screening of children. Genet Med. 2013;15(3):234–45.CrossRefPubMed
Metadaten
Titel
Overview: referrals for genetic evaluation from child psychiatrists
verfasst von
Katharine R. Press
Laura Wieczorek
Julie Hoover-Fong
Joann Bodurtha
Lynn Taylor
Publikationsdatum
01.12.2016
Verlag
BioMed Central
Erschienen in
Child and Adolescent Psychiatry and Mental Health / Ausgabe 1/2016
Elektronische ISSN: 1753-2000
DOI
https://doi.org/10.1186/s13034-016-0095-6

Weitere Artikel der Ausgabe 1/2016

Child and Adolescent Psychiatry and Mental Health 1/2016 Zur Ausgabe

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

So wirken verschiedene Alkoholika auf den Blutdruck

23.05.2024 Störungen durch Alkohol Nachrichten

Je mehr Alkohol Menschen pro Woche trinken, desto mehr steigt ihr Blutdruck, legen Daten aus Dänemark nahe. Ob es dabei auch auf die Art des Alkohols ankommt, wurde ebenfalls untersucht.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.